Bhatia Kishor G. 4
4 · Lantern Pharma Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Bhatia Kishor G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-07-15+35,000→ 35,000 totalExercise: $4.35Exp: 2034-07-15→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing August 15, 2024.